Compare OPK & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPK | ENVX |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2011 | 2020 |
| Metric | OPK | ENVX |
|---|---|---|
| Price | $1.50 | $3.46 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $1.60 | ★ $13.61 |
| AVG Volume (30 Days) | 4.3M | ★ 8.7M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.94 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $606,879,000.00 | $31,821,000.00 |
| Revenue This Year | N/A | $30.37 |
| Revenue Next Year | $4.24 | $238.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 37.91 |
| 52 Week Low | $0.98 | $3.06 |
| 52 Week High | $1.73 | $14.21 |
| Indicator | OPK | ENVX |
|---|---|---|
| Relative Strength Index (RSI) | 62.48 | 37.74 |
| Support Level | $1.26 | $3.06 |
| Resistance Level | $1.55 | $5.04 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 87.50 | 19.24 |
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.